艾昆纬：2025年妊娠期药物安全：方法和挑战报告（英文版）

Drug exposure during pregnancy is an area of critical concern, particularly for individuals managing chronic illnesses that necessitate ongoing treatment. It is estimated that approximately 10% of pregnancies involve individuals with chronic conditions such as asthma, diabetes, or hypertension.1,2 These conditions often require pharmacological intervention, which poses unique challenges in balancing maternal health needs with fetal safety. For instance, asthma treatment during pregnancy offer